LMNL-6326 | m-entrepreneurship.com

Product Name :
LMNL-6326

Search keywords :
5-oxo-ETE

drugId :
null

Target Vo:
oxoeicosanoid receptor 1

Target Vo Short Name :
OXER1

Moa_Name:
oxoeicosanoid receptor 1 antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Liminal Biosciences Inc

Active Company_Name :
Liminal Biosciences Inc

Active Indication_Name:
Dermatitis, Atopic

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
xCT Rabbit mAb custom synthesis
Brazikumab Interleukin Related
CD73 Antibody (YA797): CD73 Antibody (YA797) is a non-conjugated and Mouse origined monoclonal antibody about 63 kDa, targeting to CD73. It can be used for WB,IHC-P,IF,FC assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts